Final Glance: Pharmaceuticals companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Final Glance: Medical Devices companies
AP - Fri Apr 24, 7:08PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)
Midday Glance: Pharmaceuticals companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Midday Glance: Medical Devices companies
AP - Fri Apr 24, 12:36PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)
Baxter (BAX) Beats Q1 Earnings Estimates, Sales Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 24, 11:30AM CDT
Baxter International Inc (BAX) reported first-quarter 2015 adjusted earnings of $1.00 per share, which surpassed the Zacks Consensus Estimate by 12 cents.
BAX: 71.14 (-0.37), NKTR: 10.77 (-0.29), CHRS: 23.52 (-0.88), MCO: 107.50 (-0.26)
Early Glance: Pharmaceuticals companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37), PFE: 35.27 (-0.09), BMY: 65.80 (-0.20)
Early Glance: Medical Devices companies
AP - Fri Apr 24, 9:55AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 118.76 (+0.19), JNJ: 101.08 (+0.62), BAX: 71.14 (-0.37)
Baxter
at Investor's Business Daily - Thu Apr 23, 5:31PM CDT
Baxter (BAX), a maker of medical devices and drugs, reported Q1 EPS that fell 16% on int'l currency weakness to $1, but that topped views for 88 cents. Sales fell 5% to $3.764 bil, better than the $3.696 forecast. Shares rose 1.6% to 71.51.
BAX: 71.14 (-0.37)
Baxter International Inc.: Where a Decline Is a Win
Brian Orelli, The Motley Fool - Motley Fool - Thu Apr 23, 4:25PM CDT
Baxter 's revenue and earnings fell year over year, but shares are up today because the decline wasn't nearly as bad as investors had feared. Sales declined 2% year over year to $3.76 billion in the first quarter, but all of the decline and then...
BIIB: 401.71 (-28.57), BAX: 71.14 (-0.37)
Baxter International Rises 1.61% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:08PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $70.02 to a high of $72.07. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $70.68 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 71.14 (-0.37)
After Yesterday's Rally of 1.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 23, 4:07PM CDT
Baxter International (NYSE:BAX) traded in a range yesterday that spanned from a low of $70.02 to a high of $72.07. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $70.68 on volume of 4.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BAX: 71.14 (-0.37)
Baxter International (BAX) Earnings Report: Q1 2015 Conference Call Transcript
at The Street - Thu Apr 23, 2:15PM CDT
The following Baxter International (BAX) conference call took place on April 23, 2015, 08:30 AM ET. This is a transcript of that earnings call:
BAX: 71.14 (-0.37)
Baxter International's (BAX) CEO Bob Parkinson on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Apr 23, 1:29PM CDT
BAX: 71.14 (-0.37)
Baxter Reports First Quarter Financial Results That Exceed Guidance
M2 - Thu Apr 23, 11:40AM CDT
Baxter International Inc. (NYSE:BAX) today reported first quarter financial results that exceeded the company's previously issued guidance. Baxter reported first quarter net income of $430 million and earnings per diluted share of $0.78, compared to net income of $556 million and earnings per diluted share of $1.01 in the same period last year. First quarter 2015 results include net after-tax special items totaling $120 million (or $0.22 per diluted share), primarily for intangible asset amortization, costs associated with the company's planned separation and the integration of its Gambro AB acquisition, partially offset by a benefit related to the reversal of certain business optimization reserves. First quarter 2014 results included net after-tax charges totaling $96 million (or $0.18 per diluted share).
BAX: 71.14 (-0.37)